Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$658K Sell
2,002
-63
-3% -$22.6K ﹤0.01% 549
2025
Q4
$726K Buy
2,065
+1,332
+182% +$485K ﹤0.01% 464
2025
Q3
$271K Sell
733
-125,000
-99% -$48.3M ﹤0.01% 651
2025
Q2
$49.7M Sell
125,733
-200,002
-61% -$74.8M 0.43% 55
2025
Q1
$121M Sell
325,735
-207,498
-39% -$79M 2.32% 10
2024
Q4
$192M Buy
533,233
+425,000
+393% +$157M 3.27% 9
2024
Q3
$39.1M Buy
108,233
+57,500
+113% +$19.8M 0.89% 28
2024
Q2
$17.3M Buy
50,733
+50,000
+6,821% +$16.9M 0.46% 47
2024
Q1
$262K Sell
733
-103
-12% -$34.7K 0.01% 346
2023
Q4
$250K Sell
836
-78,276
-99% -$22M 0.01% 421
2023
Q3
$21.6M Buy
79,112
+39,112
+98% +$11.2M 3.05% 6
2023
Q2
$12.2M Buy
+40,000
New +$11.6M 2.2% 10

Other funds holding SYK

Marex Group's SYK Position: Q1 2026 in Review

Marex Group reduced its Stryker (SYK) stake by 3.1% in Q1 2026, selling an estimated $22.6K and leaving 2,002 shares worth $658K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Marex Group first reported a position in SYK in Q2 2023 and has held it in 12 quarters since. The position peaked at $192M in Q4 2024. 2,293 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Marex Group held 2,002 shares of Stryker worth $658K as of Q1 2026.
  • Marex Group sold 63 Stryker shares in Q1 2026, an estimated $22.6K.
  • Stryker made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #549 holding.
  • Marex Group first reported a position in Stryker in Q2 2023 and has held it in 12 quarters since.
  • Marex Group's Stryker position peaked at $192M in Q4 2024.
  • 2,293 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.